Published in Neuroimage on February 13, 2010
Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response | NCT01251471
Neuroimaging of child abuse: a critical review. Front Hum Neurosci (2012) 1.75
Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex (2013) 1.20
Bayesian Generalized Low Rank Regression Models for Neuroimaging Phenotypes and Genetic Markers. J Am Stat Assoc (2014) 1.10
SPReM: Sparse Projection Regression Model For High-dimensional Linear Regression. J Am Stat Assoc (2015) 1.01
Epigenetic Modulation of Mood Disorders. J Genet Syndr Gene Ther (2013) 0.98
Serotonin transporter gene polymorphisms and brain function during emotional distraction from cognitive processing in posttraumatic stress disorder. BMC Psychiatry (2011) 0.95
No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes Brain Behav (2011) 0.94
Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. Neuropsychopharmacology (2014) 0.93
5-HTTLPR-environment interplay and its effects on neural reactivity in adolescents. Neuroimage (2012) 0.87
Is there a personalized medicine for mood disorders? Eur Arch Psychiatry Clin Neurosci (2010) 0.83
Interaction of catechol O-methyltransferase and serotonin transporter genes modulates effective connectivity in a facial emotion-processing circuitry. Transl Psychiatry (2012) 0.81
Effect of genetic variant in BICC1 on functional and structural brain changes in depression. Neuropsychopharmacology (2012) 0.81
Multiple SNP Set Analysis for Genome-Wide Association Studies Through Bayesian Latent Variable Selection. Genet Epidemiol (2015) 0.80
The genetics of anxiety-related negative valence system traits. Am J Med Genet B Neuropsychiatr Genet (2016) 0.79
Serotonin transporter genotype (5-HTTLPR) and electrocortical responses indicating the sensitivity to negative emotional cues. Emotion (2013) 0.78
TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder. Neuropsychopharmacology (2014) 0.78
BDNF Val(66)Met and 5-HTTLPR Genotype are Each Associated with Visual Scanning Patterns of Faces in Young Children. Front Behav Neurosci (2015) 0.77
Association between serotonin transporter genotype, brain structure and adolescent-onset major depressive disorder: a longitudinal prospective study. Transl Psychiatry (2014) 0.77
Adolescent neurobiological susceptibility to social context. Dev Cogn Neurosci (2015) 0.76
DNA methylation of the serotonin transporter gene (SLC6A4) is associated with brain function involved in processing emotional stimuli. J Psychiatry Neurosci (2015) 0.76
Relationship between the LHPP Gene Polymorphism and Resting-State Brain Activity in Major Depressive Disorder. Neural Plast (2016) 0.75
A Set-Based Mixed Effect Model for Gene-Environment Interaction and Its Application to Neuroimaging Phenotypes. Front Neurosci (2017) 0.75
Bayesian longitudinal low-rank regression models for imaging genetic data from longitudinal studies. Neuroimage (2017) 0.75
Reproducibility of Brain Morphometry from Short-Term Repeat Clinical MRI Examinations: A Retrospective Study. PLoS One (2016) 0.75
Identifying new susceptibility genes on dopaminergic and serotonergic pathways for the framing effect in decision-making. Soc Cogn Affect Neurosci (2017) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Complex network measures of brain connectivity: uses and interpretations. Neuroimage (2009) 20.48
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Role of genotype in the cycle of violence in maltreated children. Science (2002) 13.50
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA (2009) 12.35
5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci (2005) 10.13
Stress and the brain: from adaptation to disease. Nat Rev Neurosci (2005) 9.48
Subgenual prefrontal cortex abnormalities in mood disorders. Nature (1997) 9.36
Serotonin transporter genetic variation and the response of the human amygdala. Science (2002) 9.31
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science (2006) 9.31
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell (2007) 8.99
Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry (2003) 6.93
Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science (2006) 6.71
Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry (2003) 6.52
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct (2008) 6.32
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci (2006) 5.89
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science (2006) 5.89
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet (2004) 5.70
Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci (2006) 5.70
Neurocircuitry of mood disorders. Neuropsychopharmacology (2010) 5.57
Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci (2003) 5.11
The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci (2004) 4.84
Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry (2007) 4.71
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci (2007) 4.46
A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry (2005) 4.33
Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A (1998) 4.16
Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry (2008) 3.80
The amygdala. Curr Biol (2007) 3.79
The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci (2003) 3.79
A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet (1998) 3.59
Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A (2006) 3.58
Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci (2004) 3.56
The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology (2004) 3.51
The subgenual anterior cingulate cortex in mood disorders. CNS Spectr (2008) 3.40
Predictors of amygdala activation during the processing of emotional stimuli: a meta-analysis of 385 PET and fMRI studies. Brain Res Rev (2007) 3.26
A computational theory of hippocampal function, and empirical tests of the theory. Prog Neurobiol (2006) 3.20
Contrasting roles for cingulate and orbitofrontal cortex in decisions and social behaviour. Trends Cogn Sci (2007) 3.18
Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet (2004) 3.11
Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry (2009) 2.94
Neural mechanisms of a genome-wide supported psychosis variant. Science (2009) 2.88
The role of the amygdala in emotional processing: a quantitative meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev (2008) 2.86
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One (2009) 2.85
BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry (2006) 2.79
Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci (2001) 2.77
Voxelwise genome-wide association study (vGWAS). Neuroimage (2010) 2.69
Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A (2005) 2.68
Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci (2003) 2.67
Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65
A validated network of effective amygdala connectivity. Neuroimage (2007) 2.58
Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry (2009) 2.54
Imaging genomics. Br Med Bull (2003) 2.39
A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull (2008) 2.35
The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. J Neurosci (2009) 2.35
The parahippocampal region: corticocortical connectivity. Ann N Y Acad Sci (2000) 2.34
Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry (2005) 2.29
The orbitofrontal cortex and beyond: from affect to decision-making. Prog Neurobiol (2008) 2.26
Neural correlates of epigenesis. Proc Natl Acad Sci U S A (2006) 2.24
Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci U S A (2005) 2.24
Research and treatment approaches to depression. Nat Rev Neurosci (2001) 2.24
Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci (2008) 2.21
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry (2009) 2.15
Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci U S A (2008) 2.13
Is mood chemistry? Nat Rev Neurosci (2005) 2.12
A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology (2002) 2.07
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry (2007) 2.05
The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res (2009) 2.05
Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism. J Neurosci (2009) 2.05
Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci (2005) 2.04
Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry (2006) 1.94
Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 1.87
Forum: Interactions between gene and environment. Curr Opin Psychiatry (2008) 1.86
A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry (2004) 1.85
Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry (2004) 1.85
Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet (2006) 1.82
Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry (2007) 1.80
Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology (2007) 1.80
Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry (2008) 1.79
Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77
New approaches for exploring anatomical and functional connectivity in the human brain. Biol Psychiatry (2004) 1.75
Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement. Mol Psychiatry (2008) 1.72
Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques. Proc Natl Acad Sci U S A (2004) 1.71
Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry (2008) 1.70
Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding. Eur J Neurosci (2008) 1.67
Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry (2008) 1.67
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry (2008) 1.66
Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn Neuropsychiatry (2009) 1.60
Functional and structural connectivity between the perigenual anterior cingulate and amygdala in bipolar disorder. Biol Psychiatry (2009) 1.59
A genetically mediated bias in decision making driven by failure of amygdala control. J Neurosci (2009) 1.59
Individual differences in extraversion and dopamine genetics predict neural reward responses. Brain Res Cogn Brain Res (2005) 1.55
Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry (2005) 1.55
Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry (2007) 1.54
Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch Gen Psychiatry (2009) 1.51
Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Mol Psychiatry (2007) 1.50
Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience (2009) 1.49
5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am J Med Genet B Neuropsychiatr Genet (2009) 1.49
Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Hum Brain Mapp (2009) 1.48
Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A (2006) 3.58
Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A (2005) 2.68
Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol (2007) 2.64
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology (2012) 2.28
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron (2006) 2.00
Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch Gen Psychiatry (2009) 1.75
Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry (2007) 1.73
Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol (2005) 1.73
The N terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem (2010) 1.58
Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J Biol Chem (2007) 1.49
Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study. Biol Psychiatry (2007) 1.45
Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia? Biochem Pharmacol (2007) 1.44
Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol (2005) 1.42
Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci (2008) 1.41
Membrane localization is critical for activation of the PICK1 BAR domain. Traffic (2008) 1.25
Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter. J Biol Chem (2003) 1.25
Unifying concept of serotonin transporter-associated currents. J Biol Chem (2011) 1.24
Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J Neurosci (2009) 1.22
The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter. Mol Pharmacol (2010) 1.21
Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat gamma-aminobutyric acid transporter-1 (GAT1). J Biol Chem (2004) 1.20
The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem (2012) 1.19
The suppressive influence of SMA on M1 in motor imagery revealed by fMRI and dynamic causal modeling. Neuroimage (2007) 1.19
Fully exploratory network independent component analysis of the 1000 functional connectomes database. Front Hum Neurosci (2012) 1.18
Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology (2005) 1.17
Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J Biol Chem (2012) 1.14
Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1. J Biol Chem (2007) 1.14
Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model. PLoS Comput Biol (2013) 1.14
The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the conformational switch in the transport cycle. J Biol Chem (2006) 1.13
Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J Biol Chem (2004) 1.13
Natural course and burden of bipolar disorders. Int J Neuropsychopharmacol (2003) 1.13
Sec24- and ARFGAP1-dependent trafficking of GABA transporter-1 is a prerequisite for correct axonal targeting. J Neurosci (2008) 1.12
The role of zinc ions in reverse transport mediated by monoamine transporters. J Biol Chem (2002) 1.11
The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C. J Biol Chem (2011) 1.11
Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. J Neurosci (2007) 1.11
A quantitative model of amphetamine action on the 5-HT transporter. Br J Pharmacol (2014) 1.11
Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage (2008) 1.10
Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J Biol Chem (2002) 1.09
Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter. J Biol Chem (2010) 1.08
Glycine transporter dimers: evidence for occurrence in the plasma membrane. J Biol Chem (2008) 1.07
Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux. J Biol Chem (2012) 1.04
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine. Biol Chem (2011) 1.03
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. Eur J Pharmacol (2012) 1.02
Fluorescence resonance energy transfer in the study of cancer pathways. Curr Opin Oncol (2003) 1.02
Signal-dependent export of GABA transporter 1 from the ER-Golgi intermediate compartment is specified by a C-terminal motif. J Cell Sci (2008) 1.00
The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking. J Neurosci (2011) 1.00
Multi-subject analyses with dynamic causal modeling. Neuroimage (2009) 1.00
Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate. Proc Natl Acad Sci U S A (2013) 0.99
Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biol Psychiatry (2005) 0.98
Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C. J Biol Chem (2013) 0.95
Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies. J Mol Biol (2008) 0.95
A highly parallelized framework for computationally intensive MR data analysis. MAGMA (2011) 0.94
Single molecule analysis reveals coexistence of stable serotonin transporter monomers and oligomers in the live cell plasma membrane. J Biol Chem (2014) 0.94
Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells. J Biol Chem (2011) 0.94
The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization. J Biol Chem (2011) 0.94
Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding. J Biol Chem (2012) 0.93
Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology (2007) 0.93
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest (2014) 0.92
The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein. J Biol Chem (2007) 0.92
Subtype-specific differences in corticotropin-releasing factor receptor complexes detected by fluorescence spectroscopy. Mol Pharmacol (2009) 0.91
Structure and regulatory interactions of the cytoplasmic terminal domains of serotonin transporter. Biochemistry (2014) 0.90
The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization. FASEB J (2011) 0.89
N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents. J Neurochem (2008) 0.88
The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport. J Biol Chem (2013) 0.88
A membrane network of receptors and enzymes for adenine nucleotides and nucleosides. Biochim Biophys Acta (2008) 0.88
Oligomerization of the {gamma}-aminobutyric acid transporter-1 is driven by an interplay of polar and hydrophobic interactions in transmembrane helix II. J Biol Chem (2004) 0.88
Actovegin®: a biological drug for more than 5 decades. Wien Med Wochenschr (2011) 0.86
Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology. World J Biol Psychiatry (2002) 0.85
Is there a personalized medicine for mood disorders? Eur Arch Psychiatry Clin Neurosci (2010) 0.83
Involvement of serotonin transporter extracellular loop 1 in serotonin binding and transport. Mol Membr Biol (2008) 0.83
Probing the Selectivity of Monoamine Transporter Substrates by Means of Molecular Modeling. Mol Inform (2013) 0.81
The genetic blueprint of major depressive disorder: contributions of imaging genetics studies. World J Biol Psychiatry (2011) 0.81
Imaging genetics: Progressing by leaps and bounds. Neuroimage (2010) 0.80
A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content. ACS Chem Neurosci (2012) 0.80
Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs. Mol Pharmacol (2013) 0.79
Physical exercise counteracts genetic susceptibility to depression. Neuropsychobiology (2015) 0.78
Intramolecular cross-linking in a bacterial homolog of mammalian SLC6 neurotransmitter transporters suggests an evolutionary conserved role of transmembrane segments 7 and 8. Neuropharmacology (2005) 0.78
A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1). J Med Chem (2015) 0.77
Imaging genetics: implications for research on variable antidepressant drug response. Expert Rev Clin Pharmacol (2010) 0.77
rs6295 [C]-Allele Protects Against Depressive Mood in Elderly Endurance Athletes. J Sport Exerc Psychol (2015) 0.77
Relationship between power spectra of the awake EEG and psychomotor activity patterns measured by short-term actigraphy. Neuropsychobiology (2003) 0.76
New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging. Psychiatry Clin Neurosci (2008) 0.75
Occupancy of the zinc-binding site by transition metals decreases the substrate affinity of the human dopamine transporter by an allosteric mechanism. J Biol Chem (2017) 0.75
Heterocyclic Analogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors. J Med Chem (2017) 0.75
Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications. Eur J Neurosci (2017) 0.75